FOXP3 and neuropathic pain: As shown in Fig. 1a, neuropathic pain patients exhibited significantly elevated Foxp3/CD4+ ratios (1.6 ± 0.9 in neuropathic pain vs. 0.8 ± 0.5 in healthy controls; p < 0.05).